Herb/Drug Interaction Studies Not Necessary Drug Safety Requirement – FDAer
This article was originally published in The Tan Sheet
Executive Summary
Pharmaceutical firms should not bother testing whether their drugs interact with herbal products, according to FDA Center for Drug Evaluation & Research Office of Clinical Pharmacology & Biopharmaceutics Deputy Director for Science Shiew-Mei Huang, PhD
You may also be interested in...
Herb/Drug Interaction Research Could Include Clinical, Behavioral Studies
Future research on herb/drug interactions could range from clinical trials of botanicals to behavioral studies of consumer use patterns, according to speakers at an American Society of Clinical Pharmacology & Therapeutics workshop in Bethesda, Md. July 22-23
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands